540 results on '"Tran Cao, Hop S."'
Search Results
2. Advancing minimally invasive hepato-pancreato-biliary surgery: ensuring safety with implementation
3. Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA)
4. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy
5. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools
6. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis
7. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?
8. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases
9. What Defines the Value of Minimally Invasive Surgery for Cancer Patients?
10. Defining and Refining the Role of Adjuvant Chemoradiation for Biliary Tract Cancers After SWOG 0809
11. Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma
12. A propensity score matched cost analysis of robotic versus open hepatectomy
13. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II Hepatocellular Carcinoma
14. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases
15. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software
16. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients
17. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
18. Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
19. ASO Visual Abstract: Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases
20. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy
21. ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I–II Hepatocellular Carcinoma
22. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study
23. Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022
24. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion
25. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma – does pathologic response mean better outcomes?
26. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors
27. Pancreatic Neuroendocrine Tumors
28. Contributors
29. Is There a Place for Robotic Resection?
30. Individual components of post-hepatectomy care pathways have differential impacts on length of stay
31. Robot-assisted liver resection: the real benefit so far
32. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection
33. ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
34. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer
35. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases
36. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer
37. ASO Visual Abstract: Insurance Disparities in Access to Robotic Surgery for Colorectal Cancer
38. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database
39. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite
40. Exceptional Pathologic Response to Preoperative Therapy for Colorectal Liver Metastases
41. Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience
42. Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer
43. Preliminary Analysis of Liquid Biopsy after Hepatectomy for Colorectal Liver Metastases
44. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes
45. Comparative Effectiveness of Neoadjuvant Therapy and Upfront Resection for Patients with Resectable Pancreatic Adenocarcinoma: An Instrumental Variable Analysis
46. Malnutrition in elective surgery: How traditional markers might be failing surgeons and patients
47. Short- and Long-Term Outcomes of a Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases
48. Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States.
49. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis
50. Alteration of FBXW7 is Associated with Worse Survival in Patients Undergoing Resection of Colorectal Liver Metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.